National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

Found 568 cases where Vaccine is RV1 and Symptom is Intussusception and Appearance Date from '2008-02-01' to '2014-12-31'

Case Details

This is page 35 out of 57

Result pages: prev   26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44   next


VAERS ID: 387210 (history)  
Form: Version 1.0  
Age: 0.4  
Sex: Male  
Location: Foreign  
Vaccinated:2010-03-12
Onset:2010-05-02
   Days after vaccination:51
Submitted: 2010-05-11
   Days after onset:9
Entered: 2010-05-11
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
RV1: ROTAVIRUS (ROTARIX) / GLAXOSMITHKLINE BIOLOGICALS - / 1 UN / UN

Administered by: Other       Purchased by: Other
Symptoms: Adenovirus infection, Diarrhoea, Echography abnormal, Enema administration, Inappropriate schedule of drug administration, Intestinal operation, Intussusception, Lymphadenopathy, Pyrexia, Rectal haemorrhage, Stool analysis abnormal, Vomiting
SMQs:, Acute pancreatitis (broad), Haemorrhage terms (excl laboratory terms) (narrow), Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Pseudomembranous colitis (broad), Malignancy related therapeutic and diagnostic procedures (narrow), Gastrointestinal obstruction (narrow), Gastrointestinal haemorrhage (narrow), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow), Ischaemic colitis (broad), Noninfectious diarrhoea (narrow), Medication errors (narrow), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Infective pneumonia (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, 0 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: Echography, 02May2010, lymph nodes; Stool analysis, May2010, adenovirus
CDC Split Type: B0651961A

Write-up: This case was reported by a physician and described the occurrence of invagination of intestine in a 6-month-old male subject who was vaccinated with ROTARIX (GlaxoSmithKline). On 5 February 2010 and 12 March 2010, the subject received 1st dose and 2nd dose of ROTARIX (route unknown, batch number not provided). On 2 May 2010, 51 days after vaccination with 2nd dose of ROTARIX and 86 days after vaccination with 1st dose of ROTARIX, the subject experienced ileocecal invagination of 12 cm, proctorrhagia, vomiting and lymphadenopathy (presence of lymph nodes confirmed via echography). The subject was hospitalised. He was treated with injection of contrast product (via rectum) to reduce the invagination but it was only partially successful. Then, he was operated in order to reduce completely the invagination which was fully successful without any resection of the intestine. On 3 May 2010, 52 days after vaccination with 2nd dose of ROTARIX and 87 days after vaccination with 1st dose of ROTARIX, the subject experienced fever. They excluded any post operation complication. On 4 May 2010, 53 days after vaccination with 2nd dose of ROTARIX and 88 days after vaccination with 1st dose of ROTARIX, the subject experienced diarrhea. A stool analysis was performed and showed the presence of adenovirus. At the time of reporting, the events were resolved. According to the pediatrician, this was a mechanical invagination due to the presence of lymph nodes. Further information has been expected.


VAERS ID: 389308 (history)  
Form: Version 1.0  
Age: 0.48  
Sex: Male  
Location: Foreign  
Vaccinated:2010-05-15
Onset:2010-05-15
   Days after vaccination:0
Submitted: 2010-05-25
   Days after onset:10
Entered: 2010-05-25
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
RV1: ROTAVIRUS (ROTARIX) / GLAXOSMITHKLINE BIOLOGICALS AF41FV042A / 2 UN / UN

Administered by: Other       Purchased by: Other
Symptoms: Abdominal discomfort, Abdominal rigidity, Crying, Diet refusal, Gastrointestinal oedema, Intussusception, Ultrasound abdomen abnormal
SMQs:, Acute pancreatitis (broad), Angioedema (broad), Retroperitoneal fibrosis (broad), Gastrointestinal perforation, ulcer, haemorrhage, obstruction non-specific findings/procedures (broad), Gastrointestinal obstruction (narrow), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow), Haemodynamic oedema, effusions and fluid overload (narrow), Depression (excl suicide and self injury) (broad), Hypersensitivity (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, 0 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness: unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: ultrasound abdomen, 15May2010, see text
CDC Split Type: B0653433A

Write-up: This case was reported by a physician and described the occurrence of intussusception in a 5-month-old male subject who was vaccinated with ROTARIX (GlaxoSmithKline). No significant contributory history. Previous and/or concurrent vaccination included ROTARIX vaccine; GlaxoSmithKline; unknown given on 10 April 2010. On 15 May 2010, the subject received 2nd dose of ROTARIX (route unknown). On 15 May 2010, 3 hours after vaccination with ROTARIX, the subject experienced intussusception (auto-reduction of), straining on defecation, tensed abdomen sensitive to palpation, refused to feed, crying uncontrollably and bowel wall edema revealed by an USG abdomen. The subject was hospitalised and discharged after 1 day. No surgical treatment required. The subject was treated with intravenous fluids. At the time of reporting, the events were improved. The physician considered the events were almost certainly related to vaccination with ROTARIX.


VAERS ID: 389388 (history)  
Form: Version 1.0  
Age: 0.16  
Sex: Female  
Location: Foreign  
Vaccinated:2009-08-20
Onset:2010-05-12
   Days after vaccination:265
Submitted: 2010-05-26
   Days after onset:14
Entered: 2010-05-26
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
6VAX-F: DTAP+IPV+HEPB+HIB (INFANRIX HEXA) / GLAXOSMITHKLINE BIOLOGICALS A21CA539B / UNK UN / UN
PNC: PNEUMO (PREVNAR) / PFIZER/WYETH - / UNK UN / UN
RV1: ROTAVIRUS (ROTARIX) / GLAXOSMITHKLINE BIOLOGICALS A41CA761A / UNK MO / PO

Administered by: Other       Purchased by: Other
Symptoms: Abdominal pain, Barium enema, Colectomy, Gastroenteritis, Intensive care, Intussusception, Small intestinal resection, Vomiting
SMQs:, Acute pancreatitis (broad), Retroperitoneal fibrosis (broad), Malignancy related therapeutic and diagnostic procedures (narrow), Gastrointestinal obstruction (narrow), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow), Noninfectious diarrhoea (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, 0 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: UNK
CDC Split Type: B0656738A

Write-up: This case was reported by a nurse and described the occurrence of intussusception in a 10-month-old female subject who was vaccinated with ROTARIX (GlaxoSmithKline), INFANRIX HEXA and PREVENAR (non-gsk). On 20 August 2009, the subject received an unspecified dose of ROTARIX (oral), an unspecified dose of INFANRIX HEXA (administration site and route unknown) and an unspecified dose of PREVENAR. On 21 September 2009, the subject received an unspecified dose of ROTARIX (oral). An unspecified dose of INFANRIX HEXA (administration site and route unknown) and an unspecified dose of PREVENAR. On 22 October 2009, the subject received an unspecified dose of INFANRIX HEXA (administration site and route unknown) and an unspecified dose of PREVENAR. On 12 May 2010, 7 months after vaccination with INFANRIX HEXA and PREVENAR, 8 months after vaccination with INFANRIX HEXA, PREVENAR and ROTARIX, 9 months after vaccination with INFANRIX HEXA, PREVENAR and ROTARIX, the subject experienced vomiting with severe abdominal pain. He was admitted for gastroenteritis. On 13 May 2010, intussusception was diagnosed with barium enema right hemicolectomy and a small bowel resection was done the same day. The subject was hospitalised 2 days in ICU and then ward. At the time of reporting, the outcome of the events was unspecified. Further information has been expected.


VAERS ID: 389456 (history)  
Form: Version 1.0  
Age: 0.14  
Sex: Unknown  
Location: Foreign  
Vaccinated:2010-01-06
Onset:2010-01-11
   Days after vaccination:5
Submitted: 2010-05-26
   Days after onset:134
Entered: 2010-05-27
   Days after submission:1
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
6VAX-F: DTAP+IPV+HEPB+HIB (INFANRIX HEXA) / GLAXOSMITHKLINE BIOLOGICALS 020CA635A / UNK UN / IM
PNC: PNEUMO (PREVNAR) / PFIZER/WYETH D28551 / UNK UN / IM
RV1: ROTAVIRUS (ROTARIX) / GLAXOSMITHKLINE BIOLOGICALS A41CA987A / UNK MO / PO

Administered by: Unknown       Purchased by: Unknown
Symptoms: Blood culture negative, Body temperature decreased, Gastrointestinal hypomotility, Gastrointestinal inflammation, Haematochezia, Hypotonic-hyporesponsive episode, Intussusception, Peritoneal disorder, Rash maculo-papular, Sepsis, Ultrasound abdomen abnormal
SMQs:, Haemorrhage terms (excl laboratory terms) (narrow), Retroperitoneal fibrosis (broad), Gastrointestinal perforation, ulcer, haemorrhage, obstruction non-specific findings/procedures (narrow), Gastrointestinal obstruction (narrow), Gastrointestinal haemorrhage (narrow), Gastrointestinal nonspecific inflammation (broad), Ischaemic colitis (broad), Hypotonic-hyporesponsive episode (narrow), Hypersensitivity (narrow), Noninfectious diarrhoea (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Sepsis (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, 0 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: Concomitant medications were not reported.
Current Illness:
Preexisting Conditions: Relevant medical history was not provided.
Allergies:
Diagnostic Lab Data: Body temperature (results: 35.9 deg. C.) was done on 11-Jan-2010. Additionally, blood culture (results: negative) and ultrasound abdomen (results: revealed multiple distended bowel loops with sluggish peristalsis and minimal free fluid in the peritoneal cavity) were done on an unspecified date.
CDC Split Type: PLWYEH15265210

Write-up: Information regarding PREVENAR was received from a physician (case ID: N128/2010) regarding an 8-week-old patient who experienced hypotonic-hyporesponsive episode, rash maculo-papular, body temperature decreased, intussusception, intestinal hyperemia, peritoneal disorder, stool bloody and bowel peristalsis decreased. The patient received a dose on 06-Jan-2010. The patient also received a dose of ROTARIX (GlaxoSmithKline) and a dose of INFANRIX HEXA on 06-Jan-2010. On 11-Jan-2010 the patient experienced hypotonic-hyporesponsive episode, rash maculo-papular, body temperature decreased, intussusception, intestinal hyperemia, peritoneal disorder, stool bloody and bowel peristalsis decreased. The child was hospitalised in Hospital A and then transferred to the Hospital for Infection Diseases due to suspicion of sepsis. The child required receiving KKC (?). Intussusception resolved spontaneously. The patient was recovering from hypotonic-hyporesponsive episode, rash maculo-papular, body temperature decreased, intestinal hyperemia, peritoneal disorder, stool bloody and bowel peristalsis decreased at the time of this report. No additional information was available at the time of this report.


VAERS ID: 389605 (history)  
Form: Version 1.0  
Age: 0.3  
Sex: Unknown  
Location: Foreign  
Vaccinated:0000-00-00
Onset:2010-03-01
Submitted: 2010-05-28
   Days after onset:87
Entered: 2010-05-28
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
RV1: ROTAVIRUS (ROTARIX) / GLAXOSMITHKLINE BIOLOGICALS - / UNK UN / UN

Administered by: Other       Purchased by: Other
Symptoms: Intussusception, Lymphadenitis
SMQs:, Gastrointestinal obstruction (narrow), Drug reaction with eosinophilia and systemic symptoms syndrome (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, 0 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: UNK
CDC Split Type: B0657046A

Write-up: This case was reported by a consumer and described the occurrence of invagination of intestine in a 3-month-old subject of unspecified gender who was vaccinated with ROTARIX (GlaxoSmithKline). A physician or other health care professional has not verified this report. In 2010, the subject received unspecified dose of ROTARIX (route unknown, batch number not provided). 2 days after vaccination with ROTARIX, the child was ok. In March 2010, 4 days after vaccination with ROTARIX, the subject experienced invagination of intestine and mesenteric lymphadenitis. The subject was hospitalised. At the time of reporting, the outcome of the events was unspecified. No further information is available because the subject changed his treating pediatrician.


VAERS ID: 389863 (history)  
Form: Version 1.0  
Age: 0.27  
Sex: Male  
Location: Foreign  
Vaccinated:2010-04-13
Onset:2010-04-16
   Days after vaccination:3
Submitted: 2010-06-02
   Days after onset:47
Entered: 2010-06-02
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
DTAPIPVHIB: DTAP + IPV + HIB (PENTACEL) / SANOFI PASTEUR E20661B / UNK GM / IM
HEP: HEP B (ENGERIX-B) / GLAXOSMITHKLINE BIOLOGICALS AHBVB613AH / UNK AR / IM
RV1: ROTAVIRUS (ROTARIX) / GLAXOSMITHKLINE BIOLOGICALS A41CA788A / UNK MO / PO

Administered by: Other       Purchased by: Other
Symptoms: Anxiety, Body temperature normal, C-reactive protein normal, Convulsion, Eosinophil percentage, Haemoglobin normal, Hypotonia, Intensive care, Intussusception, Lymphocyte percentage increased, Monocyte percentage increased, Pallor, Somnolence, Surgery, Ultrasound abdomen abnormal, Vomiting, White blood cell count normal
SMQs:, Acute pancreatitis (broad), Peripheral neuropathy (broad), Systemic lupus erythematosus (broad), Anticholinergic syndrome (broad), Retroperitoneal fibrosis (broad), Dementia (broad), Convulsions (narrow), Gastrointestinal obstruction (narrow), Guillain-Barre syndrome (broad), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Noninfectious meningitis (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow), Hypotonic-hyporesponsive episode (broad), Generalised convulsive seizures following immunisation (narrow), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Hypoglycaemia (broad)

Life Threatening? Yes
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, 0 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness: Unknown
Preexisting Conditions: Acute bronchitis; Cerebral ventricle dilatation
Allergies:
Diagnostic Lab Data: Body temperature, Apr2010, Normal; C-reactive protein, Apr2010, <8mg/l; Eosinophils, Apr2010, 2%; Hemoglobin, Apr2010, 129g/l; Lymphocytes, Apr2010, 62%; Monocytes, Apr2010, 11%; Physical examination, 16Apr2010, See text; Ultrasound abdomen, 16Apr2010, See text; White blood cells, Apr2010, 9.8 10*9/l
CDC Split Type: B0657076A

Write-up: This case was reported by a physician and described the occurrence of intussusception in a 3-month-old male subject who was vaccinated with ROTARIX (GlaxoSmithKline). On 13 April 2010, the subject received 1st dose of ROTARIX (1 mg, oral, batch number not provided). On 16 April 2010, 3 days after vaccination with ROTARIX, the subject became floppy and according to mother words, experienced "perhaps convulsion". The subject was brought to healthcare center, where fluid infusions were administrated. As general condition did not get better, the boy was transported to hospital and underwent surgery. The surgery diagnosed atypical intussusception. The subject was hospitalised and the physician considered the events were life threatening and clinically significant (or requiring intervention). At the time of reporting, the events were resolved. The physician considered the events were almost certainly related to vaccination with ROTARIX. Follow-up information received on 26 May 2010: The subject''s medical history included an acute bronchitis for which he was hospitalized from 24 February 2010 to 4 March 2010. Also the neurologist consulted him on 12 February 2010 because of suspected hydrocephalic syndrome. Neurosonogram has been performed and marginal increase of lateral ventricle has been found. The subject was not treated and at the second consultation of neurologist on 7 April 2010, no pathology was found. Neither the subject nor the parents had medical history of intussusception or bowel abnormalities or other gestational dysfunction. Previous vaccination included 1st dose of ENGERIX B (GlaxoSmithKline; intramuscular, unknown gluteal) on 6 January 2010. Concomitant vaccination included 2nd dose of ENGERIX B (GlaxoSmithKline; intramuscular, unknown gluteal) and 1st of PENTAXIM (Sanofi Pasteur SA; intramuscular, unknown gluteal). Batch number and expiry date of ROTARIX was provided. The subject was hospitalized on 16 April 2010, the 1st day of illness. His condition was severe; he was somnolent, flappy, pale, between times anxious. Also he vomited many of times. Physical examination was performed and abdominal infiltrate was palpated. The infiltrate was typical for intussusception. This diagnosis has been confirmed by abdominal ultrasound. On 16 April 2010, the surgery was performed: cecocolic intussusception has been found. The intussusception was extended to sigma. The bowel has been straightened during surgery. There was no need for resection. Treatment has been continued at intensive care therapy department till 19 April 2010. After that the child was in stable condition and was transferred to Pediatric Surgery Department. The child was fed with breast milk and milk formula. The stool was normal without blood and mucus additive. The abdomen was not painful, soft. The body temperature was normal. The baby''s behaviour was as usually. There was no complication of surgery. The blood test at discharge showed following results: Hemoglobin 2%; WBC 9.8 10*9/l; C reactive protein < 8 mg/l; eosinophils 2%; lymphocytes 62%; monocytes 11%; segmented leucocytes 25%. At discharge, the events were resolved. The physician considered the events were probably related to vaccination with ROTARIX.


VAERS ID: 391666 (history)  
Form: Version 1.0  
Age: 0.42  
Sex: Male  
Location: Foreign  
Vaccinated:2008-05-05
Onset:2008-05-10
   Days after vaccination:5
Submitted: 2010-06-29
   Days after onset:780
Entered: 2010-06-29
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
RV1: ROTAVIRUS (ROTARIX) / GLAXOSMITHKLINE BIOLOGICALS AROLA002AA / 2 MO / PO

Administered by: Other       Purchased by: Other
Symptoms: Abdominal distension, Crying, Haematochezia, Intussusception, Surgery, Vomiting
SMQs:, Acute pancreatitis (broad), Haemorrhage terms (excl laboratory terms) (narrow), Gastrointestinal obstruction (narrow), Gastrointestinal haemorrhage (narrow), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow), Ischaemic colitis (broad), Depression (excl suicide and self injury) (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, 0 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: UNK
CDC Split Type: B0662821A

Write-up: This case was reported by a healthcare professional via another manufacturer (Fiocruz) and described the occurrence of intussusception in a 5-month-old male subject who was vaccinated with ROTARIX (GlaxoSmithKline). On 5 May 2008, the subject received 2nd dose of ROTARIX (oral). On 10 May 2008, 5 days after vaccination with ROTARIX, the subject experienced bloody stools, abdominal distension, vomiting and crying. The subject was hospitalised and intussusception was diagnosed. The subject was treated with surgery on 13 May 2008. At the time of reporting the events were resolved. No further information could be obtained; the case has been closed.


VAERS ID: 391672 (history)  
Form: Version 1.0  
Age: 0.17  
Sex: Female  
Location: Foreign  
Vaccinated:2008-05-13
Onset:2008-05-16
   Days after vaccination:3
Submitted: 2010-06-29
   Days after onset:774
Entered: 2010-06-29
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
RV1: ROTAVIRUS (ROTARIX) / GLAXOSMITHKLINE BIOLOGICALS AROLA022CA / 1 MO / PO

Administered by: Other       Purchased by: Other
Symptoms: Abdominal pain, Crying, Intussusception, Ultrasound scan abnormal
SMQs:, Acute pancreatitis (broad), Retroperitoneal fibrosis (broad), Malignancy related therapeutic and diagnostic procedures (narrow), Gastrointestinal obstruction (narrow), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow), Depression (excl suicide and self injury) (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, 0 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: UNK
CDC Split Type: B0662820A

Write-up: This case was reported by a healthcare professional via another manufacturer (Fiocruz) and described the occurrence of intussusception in a 2-month-old female subject who was vaccinated with ROTARIX (GlaxoSmithKline). On 13 May 2008, the subject received 1st dose of ROTARIX (oral). On 16 May 2008, 3 days after vaccination with ROTARIX, the subject experienced abdominal soreness upon palpation and crying. The subject was hospitalised. An ultrasound confirmed diagnosis of intussusception. At the time of reporting the events were resolved. No further information could be obtained; the case has been closed.


VAERS ID: 391673 (history)  
Form: Version 1.0  
Age: 0.33  
Sex: Male  
Location: Foreign  
Vaccinated:2008-10-30
Onset:2008-11-02
   Days after vaccination:3
Submitted: 2010-06-29
   Days after onset:604
Entered: 2010-06-29
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
RV1: ROTAVIRUS (ROTARIX) / GLAXOSMITHKLINE BIOLOGICALS AR0LA038AA / 2 MO / PO

Administered by: Other       Purchased by: Other
Symptoms: Gastrointestinal necrosis, Intestinal resection, Intussusception, Laparotomy
SMQs:, Malignancy related therapeutic and diagnostic procedures (narrow), Gastrointestinal perforation, ulcer, haemorrhage, obstruction non-specific findings/procedures (broad), Gastrointestinal obstruction (narrow), Ischaemic colitis (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, 0 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: UNK
CDC Split Type: B0662814A

Write-up: This case was reported by a healthcare professional via another manufacturer (Fiocruz) and described the occurrence of intestinal necrosis in a 3-month-old male subject who was vaccinated with ROTARIX (GlaxoSmithKline). On 30 October 2008, the subject received 2nd dose of ROTARIX (oral). On 2 November 2008, 3 days after vaccination with ROTARIX, the subject experienced intussusception and intestine resection. 40 - 50 % of intestinal necrosis was removed. The subject was hospitalised and a laparotomy was performed. At the time of reporting the events were resolved. No further information could be obtained; the case has been closed.


VAERS ID: 391798 (history)  
Form: Version 1.0  
Age: 0.45  
Sex: Female  
Location: Foreign  
Vaccinated:2008-01-30
Onset:2008-02-18
   Days after vaccination:19
Submitted: 2010-06-30
   Days after onset:862
Entered: 2010-06-30
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
RV1: ROTAVIRUS (ROTARIX) / GLAXOSMITHKLINE BIOLOGICALS - / 2 MO / PO

Administered by: Other       Purchased by: Other
Symptoms: Colectomy, Intestinal anastomosis, Intussusception
SMQs:, Malignancy related therapeutic and diagnostic procedures (narrow), Gastrointestinal obstruction (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, 0 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: UNK
CDC Split Type: B0662908A

Write-up: This case was reported by a healthcare professional via another manufacturer (Fiocruz) and described the occurrence of intussusception in a 5-month-old female subject who was vaccinated with ROTARIX (GlaxoSmithKline). On 30 January 2008, the subject received 2nd dose of ROTARIX (oral). Lot number not provided. On 18 February 2008, 19 days after vaccination with ROTARIX, the subject experienced right jejuno-ileal intussusception which evolved to a right hemicolectomy and ileocolonic anastomosis. The subject was hospitalised. At the time of reporting the events were resolved. No further information could be obtained; the case has been closed.


Result pages: prev   26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44   next

New Search

Link To This Search Result:

https://www.medalerts.org/vaersdb/findfield.php?EVENTS=ON&PAGENO=35&SYMPTOMS[]=Intussusception_%2810022863%29&VAX[]=RV1&REPORT_YEAR_LOW=2008&REPORT_MONTH_LOW=02&REPORT_YEAR_HIGH=2014&REPORT_MONTH_HIGH=12


Copyright © 2019 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166